Dillico Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

Dillico General Information

Description

Operator of an mRNA manufacturing technology company intended to revolutionize global healthcare access through scalable, automated production of vaccines and therapeutics. The company offers All-ScaleFlow-based equipment and manufacturing infrastructure that enables continuous, digitized, and flexible production of mRNA-LNP therapies, enabling customers to manufacture millions of doses annually with minimal footprint and maximum efficiency.

Contact Information

Website
www.dillico.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2 chemin du Vieux Chêne
  • 38240 Meylan
  • France
Primary Industry
Drug Discovery
Vertical(s)
Nanotechnology
Corporate Office
  • 2 chemin du Vieux Chêne
  • 38240 Meylan
  • France

Dillico Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dillico Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 20-Oct-2026 Completed Generating Revenue
3. Early Stage VC 09-Jul-2025 Completed Generating Revenue
2. Seed Round 21-Feb-2024 $135K $135K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
To view Dillico’s complete valuation and funding history, request access »

Dillico Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary Shares
To view Dillico’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Dillico Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Dillico Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024358816-A1 Bioreactor for producing biomolecules Pending 12-Oct-2023
EP-4791852-A1 Bioreactor for producing biomolecules Pending 12-Oct-2023
WO-2025078452-A1 Bioreactor for producing biomolecules Inactive 12-Oct-2023
FR-3154122-A1 Bioreactor for the production of biomolecules Pending 12-Oct-2023
US-20260110009-A1 Process for continuous manufacture of biomolecules Pending 30-Sep-2022 C12P19/34
To view Dillico’s complete patent history, request access »

Dillico Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dillico Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
La French Tech Accelerator/Incubator
Angelor Venture Capital Minority
Bpifrance Sovereign Wealth Fund Minority
Deepbright Ventures Venture Capital Minority
GP Compas Asset Manager Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Dillico FAQs

  • When was Dillico founded?

    Dillico was founded in 2022.

  • Where is Dillico headquartered?

    Dillico is headquartered in Meylan, France.

  • What is the size of Dillico?

    Dillico has 9 total employees.

  • What industry is Dillico in?

    Dillico’s primary industry is Drug Discovery.

  • Is Dillico a private or public company?

    Dillico is a Private company.

  • What is Dillico’s current revenue?

    The current revenue for Dillico is .

  • How much funding has Dillico raised over time?

    Dillico has raised $8.85M.

  • Who are Dillico’s investors?

    La French Tech, Angelor, Bpifrance, Deepbright Ventures, and GP Compas are 5 of 9 investors who have invested in Dillico.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process